Institutions cut 10% from their holdings in the quarter ending June 2026 (3 bought, 3 sold)
Facts from SEC filings, not a recommendation.
What the price means
Price as of Oct 26
$1.84+6.4% that day
Company value
$4M
Share price times all shares
Price vs sales
1.3x
No profit over the last year, so this compares value with sales instead
Cash vs value
150%
A big cushion: cash is a large part of what the company is worth
From XBIO's last IEX trade and its SEC filings (profits and sales over the last four quarters). A starting point for research, not a verdict.
The business over time
Last 12 quarters, from SEC filings
Sales, Jun '26
$661K+12% vs a year earlier
Sep '23Tap a barJun '26
Last 12 months: $3.3M, up 33% from the 12 months before. Over 5 years, sales grew about 47% a year.
What the price assumes
Your guesses, our math
Move the sliders to your own view of XBIO. Starting points are the company's recent numbers (it isn't profitable yet, so the margin starts at a 10% guess).
Sales in 5 years$12M
Profit in 5 years$1M
Price these guesses point to$5.53+200% vs $1.84 todayAbout +25% a year, before dividends
What today's price needs: with a 10% margin and a 15x P/E, sales would have to grow about 4.3% a year for 5 years just to match today's price.
Simple math on your guesses, not a forecast or a price target. Real results depend on many things these sliders leave out.
The checklist Warren Buffett-style investors use. Annual numbers for 2025.
1/6Weak
MissReturn on equity 15%+Earns a lot on the money owners have in the business.-40.0%
PassDebt under half of equityNot relying on borrowed money.No debt reported
MissNet margin 10%+Keeps at least 10 cents of profit from each dollar of sales.-90.1%
MissProfitable every yearSteady profits, not one good year.0 of 10 years
MissFree cash flow positiveBrings in more cash than it spends to run and grow.-$2.3M
MissShare count not growingNot diluting owners. Falling means buybacks.+19.6% in 3 years
Revenue
$3.0M
+19.0% vs prior year
5-year growth
+46.8%/yr
revenue, per year
Total debt
None
0.00x equity
Current ratio
8.32x
short-term assets / bills due
From annual reports filed with the SEC. Not in this company's SEC data, so not scored: gross margin 40%+. A checklist is a starting point for research, not a verdict.
Latest quarter
Quarter ended Jun 30, 2026
Reported Aug 7
Revenue
$661K
+12.0% YoY
EPS
-$0.41
vs -$0.45
Op. margin
-147.1%
-24.3 pts
Free cash flow
-$875K
Share count
+48.8%
vs a year ago
Insider rating
Last 90 days
No open-market insider buys or sells in the last 90 days.
Weekly insider trend
No trades to chart yet.
Filing buzz
Last 7 days vs normal
0/ 100
This week
0
Normal week
0.4
vs normal
0.0x
SEC filings of any kind. 50 means a normal week.
Institutional ownership
■Steady-10.1%
Institutions cut 10.1% from their holdings. 3 bought, 3 sold. 2 quarters of net selling in a row.
Shares held by institutions152K
Sep '24Jun '26
Safety check
From SEC filings
Share count growthYearly rate, last 3 years
+15.2%
Cash runwayAt last year's cash burn
34 months
Debt to equityLatest balance sheet: debt compared with what owners have
No debt reported
Shares outstandingLatest reported
2M
Why elevated risk
Losing money, losses are large next to sales
Share count growing 15.2% a year (dilution)
1 offering filing in 6 months (may sell new shares)
Earnings reports
Last 12
Next reportAround Nov 12 (est.)Estimated from the same quarter last year
Results filedAug 7
Results filedMay 13
Results filedMar 13
Results filedNov 13, 2025
Results filedAug 13, 2025
Flags and big holders
Offerings 6 months, flags 12 months, holders 90 days